APCC announces Robotic Surgery Program for Ovarian Cancer

Conducts India’s First Robotic Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in two cases of advanced ovarian cancers reportedly .

Apollo Proton Cancer Centre (APCC), announces the launch of the Robotic Surgery Programme for Ovarian Cancers and completion of reportedly India’s First Robotic Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in two cases of advanced ovarian cancers.

 The company informs, “48-year-old. Thara, (name changed on request) from Guwahati, was suffering from carcinoma of the ovary with omental and peritoneal metastases. After receiving three cycles of neoadjuvant chemotherapy, which significantly reduced her cancer burden, she underwent a complex robotic-assisted interval cytoreductive surgery. The procedure included extensive surgical clearance, followed by HIPEC using a closed technique, which ensures precise temperature control and optimal drug distribution. She was also detected with breast cancer during her work up, she could undergo surgery for breast cancer in the same sitting. The use of robotic system enabled both the surgeries to be done with minimal morbidity and the patient was  discharged in three days.”

It further adds, “Amala, (name changed on request) a 40-year-old lady from Chennai, was battling against recurrence of a rare tumor called -extrauterine endometrial stromal sarcoma. She underwent a similar extensive robotic cytoreductive surgery, which included the removal of multiple cancer-affected tissues and organs, demonstrating the versatility and reach of robotic surgery in treating complex cancer recurrences.” 

It stated, “Compared to open CRS, robotic-assisted interval cytoreductive surgery reduce the hospital stay from over 10 days to just three days, minimised blood loss, and decreased post-operative pain. The robotic system facilitates the clinicians to access multiple deep areas of the abdomen effectively and clear the disease from there. Patients benefit from a faster return of bowel function and quicker resumption of normal activities, including timely continuation of adjuvant therapies. This, minimally invasive technology, not only enhances patient comfort and recovery but also aligns with the best outcomes.”